Preclinical models for defining efficacy of drug combinations: mapping the road to the clinic

Mol Cancer Ther. 2003 Sep;2(9):929-32.
No abstract available

Publication types

  • Congress

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Cell Culture Techniques
  • Drug Evaluation, Preclinical / methods*
  • Drug Evaluation, Preclinical / standards
  • Drug Screening Assays, Antitumor / methods
  • Humans
  • Models, Biological
  • Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents